Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 11, Pages 22933-22966
Publisher
MDPI AG
Online
2013-11-21
DOI
10.3390/ijms141122933
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
- (2013) Giovanni Targher et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
- (2013) Derrick M. Van Rooyen et al. JOURNAL OF HEPATOLOGY
- Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
- (2013) Thomas Klein et al. Medical Molecular Morphology
- Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
- (2013) A. N. Mavrogiannaki et al. International Journal of Endocrinology
- Association between metabolic syndrome and the development of non-alcoholic fatty liver disease
- (2013) YI WANG et al. Experimental and Therapeutic Medicine
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
- (2012) James L. Trevaskis et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
- (2012) I. N. Colmers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway
- (2012) Wei Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet
- (2012) Julio Cesar Fraulob et al. CLINICAL SCIENCE
- Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome: Relationships with coronary artery calcium in 10,153 people
- (2012) K.-C. Sung et al. DIABETES CARE
- Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes
- (2012) Y.-S. Lee et al. DIABETOLOGIA
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
- (2012) Takashi Nakahara et al. HEPATOLOGY RESEARCH
- Liver and diabetes. A vicious circle
- (2012) Paola Loria et al. HEPATOLOGY RESEARCH
- The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
- (2012) Fadila Benhamed et al. JOURNAL OF CLINICAL INVESTIGATION
- Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats
- (2012) Yoshihisa Okada et al. LIVER INTERNATIONAL
- Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
- (2012) Matthias Kern et al. PLoS One
- Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
- (2012) Yuki Kita et al. PLoS One
- GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
- (2012) Edwin T. Parlevliet et al. PLoS One
- Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
- (2011) E. Boettcher et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease
- (2011) Giovanni Musso et al. CURRENT OPINION IN LIPIDOLOGY
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
- (2011) S. Bonapace et al. DIABETES CARE
- Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
- (2011) R. M. Williamson et al. DIABETES CARE
- The Role of Metformin in the Management of NAFLD
- (2011) Angela Mazza et al. Experimental Diabetes Research
- Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
- (2011) Tomoyuki Iwasaki et al. HEPATO-GASTROENTEROLOGY
- Interrelationship between Fatty Liver and Insulin Resistance in the Development of Type 2 Diabetes
- (2011) Ki-Chul Sung et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in Rats
- (2011) Guiyuan Ji et al. Lipids in Health and Disease
- Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment
- (2011) Briohny W. Smith et al. Nature Reviews Endocrinology
- Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
- (2011) Soo Jin Yang et al. PLoS One
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
- (2011) N. Kumashiro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
- (2011) Shira Zelber-Sagi WORLD JOURNAL OF GASTROENTEROLOGY
- The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis
- (2011) Lisa B. Van Wagner et al. Therapeutic Advances in Gastroenterology
- Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis
- (2010) M. O. Rakoski et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series
- (2010) Patrick R Kenny et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
- (2010) Temitope Foster et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
- (2010) Giovanni Musso et al. ANNALS OF MEDICINE
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study
- (2010) Elizabeth K. Speliotes et al. HEPATOLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
- (2010) G A Garinis et al. INTERNATIONAL JOURNAL OF OBESITY
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
- (2010) Shani Ben-Shlomo et al. JOURNAL OF HEPATOLOGY
- Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism
- (2010) C. Pramfalk et al. JOURNAL OF INTERNAL MEDICINE
- Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
- (2010) Luuk J. Rijzewijk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
- (2010) Vasilios G Athyros et al. LANCET
- Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
- (2010) Nathalie C. Leite et al. LIVER INTERNATIONAL
- Animal models of nonalcoholic fatty liver disease
- (2010) Lionel Hebbard et al. Nature Reviews Gastroenterology & Hepatology
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice
- (2010) Yue-Min Nan et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Treatment of nonalcoholic fatty liver disease in children: TONIC trial design
- (2009) Joel E. Lavine et al. Contemporary Clinical Trials
- Alanine Aminotransferase, -Glutamyltransferase, and Incident Diabetes: The British Women's Heart and Health Study and meta-analysis
- (2009) A. Fraser et al. DIABETES CARE
- Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase
- (2009) O. Bourron et al. DIABETOLOGIA
- Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
- (2009) Ziya Omer et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Angiotensin II Activates IκB Kinase Phosphorylation of RelA at Ser536 to Promote Myofibroblast Survival and Liver Fibrosis
- (2009) Fiona Oakley et al. GASTROENTEROLOGY
- Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-Ay mice
- (2009) Tomonori Aoyama et al. HEPATOLOGY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes
- (2009) S. T. Hwang et al. INTERNAL MEDICINE JOURNAL
- Additive action of 11β-HSD1 inhibition and PPAR-γ agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats
- (2009) M Berthiaume et al. INTERNATIONAL JOURNAL OF OBESITY
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- GRP78 expression inhibits insulin and ER stress–induced SREBP-1c activation and reduces hepatic steatosis in mice
- (2009) Hélène L. Kammoun et al. JOURNAL OF CLINICAL INVESTIGATION
- Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup
- (2009) Tamaki Yamada et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006
- (2009) G. Targher et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
- (2009) E. Fabbrini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis of non-alcoholic fatty liver disease
- (2009) J. K. Dowman et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
- (2009) William W. Shields et al. Therapeutic Advances in Gastroenterology
- The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
- (2008) A. Nar et al. ACTA DIABETOLOGICA
- Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
- (2008) R. IDILMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Identification and Characterization of Metabolically Benign Obesity in Humans
- (2008) Norbert Stefan ARCHIVES OF INTERNAL MEDICINE
- Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
- (2008) Hyeon Chang Kim et al. ATHEROSCLEROSIS
- The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis
- (2008) A. Blum et al. ATHEROSCLEROSIS
- The role of mitochondrial glycerol-3-phosphate acyltransferase-1 in regulating lipid and glucose homeostasis in high-fat diet fed mice
- (2008) Misak Yazdi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Selective versus Total Insulin Resistance: A Pathogenic Paradox
- (2008) Michael S. Brown et al. Cell Metabolism
- Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults
- (2008) C.-H. Kim et al. DIABETIC MEDICINE
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
- Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
- (2008) Silvia Sookoian et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease: The mist gradually clears
- (2008) Nimantha Mark Wilfred de Alwis et al. JOURNAL OF HEPATOLOGY
- Hepatic triacylglycerol accumulation and insulin resistance
- (2008) Cynthia A. Nagle et al. JOURNAL OF LIPID RESEARCH
- Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice
- (2008) Kaori Minehira et al. JOURNAL OF LIPID RESEARCH
- Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
- (2008) G. Targher et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Relationship of Serum γ-Glutamyltransferase to Atherogenic Dyslipidemia and Glycemic Control in Type 2 Diabetes
- (2008) Giacomo Zoppini et al. Obesity
- Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents
- (2008) Kristen J Nadeau et al. PEDIATRIC DIABETES
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now